#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Matthew Scholz Email
CEO . Oisin Biotechnologies
Seattle, WA
LocationPrimary Email
How to contact Matthew Scholz
Join and see Matthew's contact info for free!Current Roles
Employees:
20Revenue:
$1.6MAbout
Oisin Biotechnologies is a longevity therapeutics platform company focused on creating genetic medicines to combat a variety of age related diseases. When cells detect that they have been irreversibly damaged, they enter a non-dividing condition known as cell-cycle arrest, or senescence. It’s believed this occurs to prevent cells from going rogue and turning cancerous. Ideally, they should die by the process known as apoptosis, but as we age, more and more frequently they don’t. They become zombie cells – unable to kill themselves or resume normal function. Senescent cells secrete molecules that cause inflammation in an effort to attract immune cells that would usually clear them. But for reasons that are not fully known, as we age, persistently senescent cells accumulate, leading to a vast number of age-related diseases. Oisín Biotechnologies is developing a highly precise, DNA-targeted intervention to clear these cells. As a recent study has shown, clearing senescent cells both reduces negative effects of aging pathologies and also extends median lifespan and survival.Oisin Biotechnologies Address
701 Fifth AveSeattle, WA
United States